BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22561705)

  • 1. Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells.
    Veeramani S; Chou YW; Lin FC; Muniyan S; Lin FF; Kumar S; Xie Y; Lele SM; Tu Y; Lin MF
    Free Radic Biol Med; 2012 Jul; 53(1):95-108. PubMed ID: 22561705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells.
    Veeramani S; Yuan TC; Lin FF; Lin MF
    Oncogene; 2008 Aug; 27(37):5057-68. PubMed ID: 18504439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mitochondrial reactive oxygen species regulator p66Shc controls PDGF-induced signaling and migration through protein tyrosine phosphatase oxidation.
    Frijhoff J; Dagnell M; Augsten M; Beltrami E; Giorgio M; Östman A
    Free Radic Biol Med; 2014 Mar; 68():268-77. PubMed ID: 24378437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p66Shc longevity protein regulates the proliferation of human ovarian cancer cells.
    Muniyan S; Chou YW; Tsai TJ; Thomes P; Veeramani S; Benigno BB; Walker LD; McDonald JF; Khan SA; Lin FF; Lele SM; Lin MF
    Mol Carcinog; 2015 Aug; 54(8):618-31. PubMed ID: 24395385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance.
    Miller DR; Ingersoll MA; Chatterjee A; Baker B; Shrishrimal S; Kosmacek EA; Zhu Y; Cheng PW; Oberley-Deegan RE; Lin MF
    Free Radic Biol Med; 2019 Aug; 139():24-34. PubMed ID: 31100478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine-317 of p52(Shc) mediates androgen-stimulated proliferation signals in human prostate cancer cells.
    Lee MS; Igawa T; Lin MF
    Oncogene; 2004 Apr; 23(17):3048-58. PubMed ID: 14990987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p66Shc regulates migration of castration-resistant prostate cancer cells.
    Ingersoll MA; Chou YW; Lin JS; Yuan TC; Miller DR; Xie Y; Tu Y; Oberley-Deegan RE; Batra SK; Lin MF
    Cell Signal; 2018 Jun; 46():1-14. PubMed ID: 29462661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis.
    Rajendran M; Thomes P; Zhang L; Veeramani S; Lin MF
    Cancer Metastasis Rev; 2010 Mar; 29(1):207-22. PubMed ID: 20111892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of antioxidant heme oxygenase-1 and pro-oxidant p66Shc in promoting advanced prostate cancer progression.
    Miller DR; Ingersoll MA; Chou YW; Kosmacek EA; Oberley-Deegan RE; Lin MF
    Free Radic Biol Med; 2022 Nov; 193(Pt 1):274-291. PubMed ID: 36265795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroids up-regulate p66Shc longevity protein in growth regulation by inhibiting its ubiquitination.
    Kumar S; Kumar S; Rajendran M; Alam SM; Lin FF; Cheng PW; Lin MF
    PLoS One; 2011 Jan; 6(1):e15942. PubMed ID: 21264241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diallyl trisulfide-induced prostate cancer cell death is associated with Akt/PKB dephosphorylation mediated by P-p66shc.
    Borkowska A; Sielicka-Dudzin A; Herman-Antosiewicz A; Wozniak M; Fedeli D; Falcioni G; Antosiewicz J
    Eur J Nutr; 2012 Oct; 51(7):817-25. PubMed ID: 22020565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells.
    Meng TC; Lee MS; Lin MF
    Oncogene; 2000 May; 19(22):2664-77. PubMed ID: 10851066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress stimulates apoptosis and activates NF-kappaB in osteoblastic cells via a PKCbeta/p66shc signaling cascade: counter regulation by estrogens or androgens.
    Almeida M; Han L; Ambrogini E; Bartell SM; Manolagas SC
    Mol Endocrinol; 2010 Oct; 24(10):2030-7. PubMed ID: 20685851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic nicotine exposure augments renal oxidative stress and injury through transcriptional activation of p66shc.
    Arany I; Clark J; Reed DK; Juncos LA
    Nephrol Dial Transplant; 2013 Jun; 28(6):1417-25. PubMed ID: 23328708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth.
    Chuang TD; Chen SJ; Lin FF; Veeramani S; Kumar S; Batra SK; Tu Y; Lin MF
    J Biol Chem; 2010 Jul; 285(31):23598-606. PubMed ID: 20498373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.
    Xi G; Shen X; Clemmons DR
    Mol Endocrinol; 2008 Sep; 22(9):2162-75. PubMed ID: 18606861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p66Shc protein controls redox signaling and oxidation-dependent DNA damage in human liver cells.
    Perrini S; Tortosa F; Natalicchio A; Pacelli C; Cignarelli A; Palmieri VO; Caccioppoli C; De Stefano F; Porro S; Leonardini A; Ficarella R; De Fazio M; Cocco T; Puglisi F; Laviola L; Palasciano G; Giorgino F
    Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(10):G826-40. PubMed ID: 26336926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells.
    Veeramani S; Igawa T; Yuan TC; Lin FF; Lee MS; Lin JS; Johansson SL; Lin MF
    Oncogene; 2005 Nov; 24(48):7203-12. PubMed ID: 16170380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p66Shc protein is upregulated by steroid hormones in hormone-sensitive cancer cells and in primary prostate carcinomas.
    Lee MS; Igawa T; Chen SJ; Van Bemmel D; Lin JS; Lin FF; Johansson SL; Christman JK; Lin MF
    Int J Cancer; 2004 Feb; 108(5):672-8. PubMed ID: 14696093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T; Lin FF; Rao P; Lin MF
    Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.